These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 4056986)

  • 1. Theophylline absorption in young asthmatic children receiving sustained-release formulations.
    Haltom JR; Szefler SJ
    J Pediatr; 1985 Nov; 107(5):805-10. PubMed ID: 4056986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.
    Hendeles L; Iafrate RP; Weinberger M
    Clin Pharmacokinet; 1984; 9(2):95-135. PubMed ID: 6370542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption characteristics of once-a-day slow-release theophylline preparation in children with asthma.
    Pedersen S; Steffensen G
    J Pediatr; 1987 Jun; 110(6):953-9. PubMed ID: 3585612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steady-state evaluation of twice-a-day dosing of a new sustained-release theophylline preparation for young children.
    Welch MJ; Kemp JP; Orgel HA; Meltzer EO
    J Asthma; 1985; 22(5):249-52. PubMed ID: 4055657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
    Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM
    Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inconsistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children.
    Rogers RJ; Kalisker A; Wiener MB; Szefler SJ
    J Pediatr; 1985 Mar; 106(3):496-501. PubMed ID: 3973788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation of product formulation to absorption of oral theophylline.
    Weinberger M; Hendeles L; Bighley L
    N Engl J Med; 1978 Oct; 299(16):852-7. PubMed ID: 692577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability and diurnal variation in absorption of sustained release theophylline in asthmatic children.
    Coulthard KP; Birkett DJ; Lines DR; Grgurinovich N; Grygiel JJ
    Eur J Clin Pharmacol; 1983; 25(5):667-72. PubMed ID: 6686557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food and fasting absorption of a single dose of a sustained release theophylline sprinkle formulation in children.
    Pedersen S; Steffensen G
    Allergy; 1986 Jan; 41(1):46-50. PubMed ID: 3963315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of formulation and dosing interval to fluctuation of serum theophylline concentration in children with chronic asthma.
    Weinberger M; Hendeles L; Wong L
    J Pediatr; 1981 Jul; 99(1):145-52. PubMed ID: 7252652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a 12-hour sustained-release preparation in maintaining therapeutic serum theophylline levels in asthmatic children.
    Kelly HW; Murphy S
    Pediatrics; 1980 Jul; 66(1):97-102. PubMed ID: 7402798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theophylline levels after single daily and divided dosing of a once-a-day theophylline preparation in asthmatic children.
    Boner AL; Sette L; Vallone G; Plebani M; Messori A
    Ann Allergy; 1989 Feb; 62(2):149-53. PubMed ID: 2919803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian variation in the absorption of three sustained release theophylline products in asthmatic children and the effect of food on absorption of Somophyllin-CRT.
    Birkett DJ; Coulthard KP; Lines D; Grgurinovich N
    Br J Clin Pract Suppl; 1984; 35():17-23. PubMed ID: 6433954
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the absorption kinetics of theophylline in the steady state, following multiple oral dosing of a sustained-release theophylline tablet formation to asthmatic patients.
    Takagi K; Hasegawa T; Ogura Y; Satake T; Mizukami Y
    Chem Pharm Bull (Tokyo); 1986 Sep; 34(9):3894-9. PubMed ID: 3815610
    [No Abstract]   [Full Text] [Related]  

  • 15. Simultaneous use of rapidly absorbed and sustained release theophylline preparations in children.
    Hein EW; Domson JF; Sheen A; Buffone GJ; Sly RM
    Ann Allergy; 1979 Oct; 43(4):217-9. PubMed ID: 555597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theophylline product and dosing interval selection for chronic asthma.
    Hendeles L; Weinberger M
    J Allergy Clin Immunol; 1985 Aug; 76(2 Pt 2):285-91. PubMed ID: 4019956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two new controlled-release theophylline formulations in the management of asthma in children and reliability of salivary theophylline concentration.
    Boner AL; Bennati D; Miglioranzi P; Gaburro D
    J Asthma; 1986; 23(4):195-202. PubMed ID: 3531149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline.
    Sallent J; Hill M; Stecenko A; McKenzie M; Hendeles L
    Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the pharmacodynamics and pharmacokinetics of theophylline.
    Hendeles L; Massanari M; Weinberger M
    Chest; 1985 Aug; 88(2 Suppl):103S-111S. PubMed ID: 3893922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and pharmacokinetic concerns of 24-hour dosing with theophylline.
    Weinberger M
    Ann Allergy; 1986 Jan; 56(1):2-12. PubMed ID: 3511775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.